
About eMolecules
eMolecules is a company based in San Diego (United States) founded in 2005. The company has 100 employees. eMolecules has completed 2 acquisitions, including Specs Compound Handling and Synple Chem. eMolecules offers products and services including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry. eMolecules operates in a competitive market with competitors including ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.
- Headquarter San Diego, United States
- Employees 100
- SectorsHealthcare
- Website search.emolecules.com
- Social LinkedIn
- Investors
- Employee Count100
- Investments & AcquisitionsSpecs Compound Handling
& 1 more
Products & Services of eMolecules
eMolecules offers a comprehensive portfolio of products and services, including Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.
Platform for searching and ordering chemical compounds from suppliers.
Service for reformatting chemicals into required formats.
Catalog of chemical building blocks for research purposes.
Collection of compounds for drug screening applications.
Tailored chemistry services for specific research needs.
Funding Insights of eMolecules
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of eMolecules with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | – | Private Equity Round | β | Avista Capital Partners | β |
1 investors in total: 1 institutional.
Investors in eMolecules
eMolecules has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Avista Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are focused on the United States market. | – | avistacap.com | New York, United States |
Investor details for eMolecules
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of eMolecules
16 people are tracked at eMolecules (7 in leadership, 9 in team); the tracked headcount is 100.
| Name | Role | Group |
|---|---|---|
Niko Gubernator, Ph.D. | Chief Executive Officer, eMolecules Inc. | Leadership |
Janine Holmes | Vice President Human Resources | Leadership |
Anthony Calabria | VP Operations, Site Lead | Leadership |
Jeff Desroches | Senior Vice President, Corporate Development | Leadership |
Jeff Blazevich | Chief Financial Officer | Leadership |
Larry Tang | Director of Supplier Management | Leadership |
David James | Senior Vice President Strategic Business Development | Leadership |
Elle O'Reilly | Staff Accountant | Team |
Mra Page | Senior Laboratory/logistics Technician(dg Qualified) | Team |
Jolene Tate, CPA | Controller | Team |
Brennan Gregory | Supervisor, Supply Chain and Procurement Operations | Team |
Lester Marrison | SVP Operations | Team |
Scott T. Snyder | Svp, GM Compound Management | Team |
Marvin Pagdanganan | Accounts Receivable Specialist | Team |
Paul Burke | Svp, GM Chemical Compound Procurement | Team |
Francisco Lopez | Operations Associate | Team |
Complete people profiles for eMolecules
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eMolecules
eMolecules has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Specs Compound Handling and Synple Chem.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Automated chemical synthesizers are developed using reagent capsules. | synplechem.com | Zurich, Switzerland | 2016 | Sep 2024 | β’β’β’β’ | |
Contract research and compound management services are provided globally. | specs.net | Zoetermeer, Netherlands | 1987 | May 2023 | β’β’β’β’ |
Complete acquisition details for eMolecules
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of eMolecules
4 dated milestones of eMolecules across 19 years, from founding to its latest funding, stage changes and deals.
- Founded eMolecules is founded.
- Funding First funding round.
- Acquisition Acquires Specs Compound Handling.
- Acquisition Acquires Synple Chem.
Competitors of eMolecules
eMolecules operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProQuest, ResearchGate, Authorea, Research Solutions and Mendeley, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| proquest.com | 2008 | Ann Arbor, United States | – | – | Research content is delivered via online platforms to libraries. | |
| researchgate.net | 2008 | Berlin, Germany | $87.6M | 1 | Online community for scientists | |
| authorea.com | 2012 | New York, United States | $2.11M | 88 | Collaborative platform for research and learning | |
| researchsolutions.com | 2006 | Henderson, United States | $12.06M | 34 | AI-powered solutions for scholarly content access and management are provided. | |
| mendeley.com | 2007 | London, United Kingdom | $6.6M | – | Research management and collaboration are enabled via a web/mobile platform. | |
| gcore.com | 2011 | Luxembourg | $60M | – | Collaborative learning and resource sharing for researchers are facilitated. | |
| consensus.app | 2020 | Boston, United States | $19.23M | 6 | AI-enabled search tools for life sciences research are provided. | |
| hypothes.is | 2011 | San Francisco, United States | – | 55 | An open annotation platform is offered for web-based discussions. |
Detailed competitors of eMolecules
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of eMolecules
The website of eMolecules (emolecules.com) receives about 20K visits a month.
- Monthly visits20K
▼ 14.5% vs previous month
Websites whose visitors overlap most with eMolecules. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chemspider.com | chemspider.com | 100% | – | #150,679 | β |
chemdoodle.com | chemdoodle.com | 100% | – | #513,264 | β |
rdchemicals.com | rdchemicals.com | 99% | – | #6,167,352 | β |
chemexper.com | chemexper.com | 98% | – | #3,036,858 | β |
| chemsynthesis.com | 92% | – | #2,235,894 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 32 similar websites and full traffic analytics for eMolecules
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 32 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Emolecules
Complete news archive for eMolecules
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to eMolecules
10 companies that operate in the same segment as eMolecules (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about eMolecules
eMolecules was founded in 2005 and raised its 1st funding round 16 years after it was founded.
eMolecules is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
eMolecules has 100 employees.
eMolecules was founded in 2005 in San Diego, United States. An online platform is operated by the company within the biotechnology sector, focusing on drug discovery. Services include a search engine that accesses uncharted chemical and biological compounds. Users are enabled to explore and source these materials for research purposes. The domain emolecules.com is utilized for operations, serving global pharmaceutical and research needs.
eMolecules's top competitors include ProQuest, ResearchGate and Research Solutions.
eMolecules offers Chemical Search Platform, Compound Reformatting, Building Blocks, Screening Compounds, and Custom Chemistry.
eMolecules has made 2 acquisitions, including Specs Compound Handling, and Synple Chem.
eMolecules has 1 investor. Key investors include Avista Capital Partners.
